Priority Date: 07.10.15 (US 201562238652P)

ACTIVATION OF IMMUNE-RELATED SIGNALLING PATHWAYS IN CELLS VIA OPTOFECTION

  • Application ID: EP16854471
  • Status: Request for examination was made

Attorneys

operating since 1927
Headquarter in Munich
active in Legal Services
no operation time available
active in Legal Services
Company dna lorenz and kopf partg mbb
no operation time available
5 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Danner BioPharm IP is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 173 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 07.10.2015 - Priority Date (US 201562238652P)
  • 13.04.2017 - Publication A1 (WO2017062838)
  • 15.08.2018 - Publication A1 (EP3359675)